DRC offer expiry
29 April 2002 - 5:00PM
UK Regulatory
RNS Number:1951V
Cambridge Antibody Tech Group PLC
29 April 2002
02/CAT/17
Not for release in Australia, Japan and the Republic of Ireland
FOR IMMEDIATE RELEASE
22:00 EST April 26, 2002, 03:00 GMT 27 April 2002
For Further Information Contact:
Cambridge Antibody Technology Weber Shandwick Square Mile (Europe)
Tel: +44 (0) 1763 263 233 Tel: +44 (0) 20 7950 2800
John Aston, Finance Director Kevin Smith
Rowena Gardner, Head of Corporate Graham Herring
Communications
BMC Communications/The Trout Group (USA)
Tel: 001 212 477 9007
Brad Miles, ext 17 (media)
Brandon Lewis, ext.15 (investors)
EXPIRY OF BID
BY CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
FOR DRUG ROYALTY CORPORATION INC.
Melbourn, UK and Toronto, Canada... Cambridge Antibody Technology Group plc
("CAT") (LSE: CAT; NASDAQ: CATG) has announced that its offer, through its
wholly-owned subsidiary 3982904 Canada Inc., for Drug Royalty Corporation Inc.
(TSE: DRI) expired in accordance with its terms at 9:00 p.m. EST on April 26,
2002 without the conditions to the offer having been satisfied. CAT has not
extended the offer.
-ENDS-
This information is provided by RNS
The company news service from the London Stock Exchange
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024